Patents
Patents for C07C 271 - Derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups (15,621)
02/2005
02/17/2005US20050038035 Heterocyclic amide compounds as apolipoprotein b inhibitors
02/17/2005US20050038002 Bactericides; antitumor agents; moderators of gene expression; viricides; parasiticides; malaria therapy
02/17/2005CA2531796A1 Aryl and heteroaryl compounds, compositions, and methods of use
02/16/2005EP1506954A1 4-alkyl-2-haloaniline derivative and process for producing the same
02/16/2005EP1506168A2 Gelling agents
02/16/2005EP1339675B1 Ortho-substituted and meta-substituted bis-aryl compounds, method for the production thereof, their use as a medicament, and pharmaceutical preparations containing these compounds
02/16/2005CN1189446C New derivatives of 6-(4-phenylbutoxy) hexylamine and process for producing salmeterol
02/15/2005US6855843 Antihistamines; rheumatic diseases; antidiabetic agents; inflammatory bowel disorders
02/10/2005WO2004077511A3 (meth)acrylic and (meth)acrylamide monomers, polymerizable compositions, and polymers obtained
02/10/2005WO2003099338A3 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
02/10/2005US20050032845 1,1-and 1,2-disubstituted cyclopropane compounds
02/10/2005US20050032831 Histone deacetylase inhibitors and methods of use thereof
02/10/2005US20050032787 Pheny (alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity
02/09/2005EP1504022A2 Process for the synthesis of peptide amides by side-chain attachment to a solid phase
02/09/2005EP1503981A2 Substituted tetracycline compounds
02/09/2005EP1358244A4 Polyols containing carboxyl groups and production thereof
02/09/2005EP1313560A4 CATALYST FOR AROMATIC C-O, C-N, and C-C BOND FORMATION
02/09/2005EP0900210B1 Antivirally active heterocyclic azahexane derivatives
02/09/2005CN1578659A Modulators of peroxisome proliferator activated receptors (ppar)
02/09/2005CN1188443C Polyurethane having hydroxy function of t-amino-formate bond
02/09/2005CN1188390C Process for synthesis of palycarbamates
02/09/2005CN1188388C Aminobenzophenones as inhibitors of interleukin and TNF
02/09/2005CN1188121C Therapeutic substituted guanidines
02/08/2005US6852889 Antioxidant nitroxides and nitrones as therapeutic agents
02/08/2005US6852887 Dehalogenation, amination; a viricides treating Human immunodeficiency virus (HIV), Acquired immunodeficiency syndrome (AIDS)
02/08/2005CA2130754C Amine derivatives of oxo- and hydroxy-substituted hydrocarbons
02/08/2005CA2096525C Retroviral protease inhibitors
02/08/2005CA2096409C Retroviral protease inhibitors
02/08/2005CA2096408C Retroviral protease inhibitors
02/03/2005WO2005010011A2 Methods of synthesis of acyloxyalkyl compounds
02/03/2005WO2005009944A1 Prodrugs of 9-aminomethyl tetracycline compounds
02/03/2005WO2005009943A2 Substituted tetracycline compounds
02/03/2005WO2005009940A1 Novel aminobenzophenone compounds
02/03/2005WO2005009928A2 Preparation and use of alkylating agents
02/03/2005WO2004072102A3 Benzene acetamide compounds useful as serine protease inhibitors
02/03/2005US20050026994 Treating proliferative diseases such as tumors; 4-[4-(2-Benzyloxycarbonylamino-3-methyl-butyrylamino)-3-hydroxy-2-(4-methoxy-benzylamino)-5-phenyl-pentanoylamino]4-(2-hydroxy-4-methoxy-benzylcarbamoyl)-butyric acid methyl ester for example
02/03/2005US20050026940 Processes for the preparation of substituted bicyclic derivatives
02/03/2005CA2538520A1 Preparation and use of alkylating agents
02/03/2005CA2531728A1 Substituted tetracycline compounds
02/03/2005CA2530302A1 Novel aminobenzophenone compounds
02/02/2005EP1502914A1 Process for the preparation of 1-amino-4-(hydroxymethyl)-2-cyclopentene derivatives
02/02/2005EP1244610A4 Improved preparation of 2s,3s-n-isobutyl-n-(2-hydroxy-3-amino-4-phenylbutyl)-p-nitrobenzenesulfonylamide hydrochloride and other derivatives of 2-hydroxy-1,3-diamines
02/02/2005CN1575273A 3, 4-di-substituted cyclobutene-1, 2-diones as CXC-chemokine receptor antagonists
02/02/2005CN1572786A Uracil compounds and use thereof
02/02/2005CN1187345C Method for preparing N-[1-(S)-carbethoxy-3-hydrocinnamyl] -L-alanine-N-carboxy acid anhydride
02/02/2005CN1187340C Uracil compound and its use
02/02/2005CN1187322C Method for producing aryl-iminomethyl-carbamic acid esters
02/01/2005US6849760 Organic acid and inorganic acid salts of chiral amine alcohol intermediates.
02/01/2005US6849750 2-amino-propionates
02/01/2005CA2362698C Resorcinol derivatives
01/2005
01/27/2005WO2005007810A2 Functional synthetic molecules and macromolecules for gene delivery
01/27/2005WO2005007614A1 Monoamine oxidase inhibitors
01/27/2005WO2005007091A2 Histone deacetylase inhibitors and methods of use thereof
01/27/2005US20050020849 via non-racemic cinchona-alkaloid-type catalyst (quinidine) for addition of nucleophile
01/27/2005US20050020689 Process and intermediates for the preparation of 3-(amino)-3-cyclobutylmethyl-2-hydroxy-propionamide or salts thereof
01/27/2005CA2800212A1 Histone deacetylase inhibitors and methods of use thereof
01/26/2005EP1499898A2 Regulation of tnf-alpha
01/26/2005EP1499645A1 Incorporable photoinitiator
01/25/2005US6846939 Minocycline compound substitued at 9-position by a group selected from nitro, alkyl, alkenyl, alkynyl, aryl, alkoxy, alkylthio, alkylsufinyl, alkylsulfonyl, amino, thionitroso, arylalkynyl or carbamate, urea, and sulfonamide
01/25/2005US6846813 For inhibiting beta-secretase enzyme activity and A beta peptide production, inhibition of beta-secretase enzyme activity halts or reduces production of A beta from APP and reduces or eliminates the formation of beta-amyloid deposits
01/20/2005US20050014839 Histone deacetylase inhibitors and methods of use thereof
01/20/2005US20050014721 reacting oxabenzonorbornadiene with nucleophiles;in presence of rhodium complex catalyst forming 2-pyrrolidin-1-ol-1,2-dihydronaphthalen-1-ol; drug used as analgesics, Parkinson's disease, anticancer agents; aids
01/20/2005US20050012092 (4,5,9,10-Tetrahydro-pyren-2-yl)-carbamic acid 4-(2-methylsulfanyl-alkyl)-3,5-dinitro-benzyl ester, method of synthesizing thereof, and molecular electronic device using the same
01/19/2005EP1498406A1 Novel hydronaphthalene compounds, prepared by a rhodium catalysed ring opening reaction in the presence of phosphine ligand
01/19/2005EP1497247A2 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses
01/19/2005EP1496838A2 Substituted amides
01/19/2005CN1568304A Process for the preparation of enantiomerically-enriched cyclopropylalanine derivatives
01/13/2005US20050009906 e.g., N-{4-[3-(4-Hydroxy-piperidin-1-yl)-3-oxo-propoxy]-cyclohexyl}-N-methyl-4-trifluoromethyl-benzenesulfonamide and p-chlorophenyl methyl-(2-{4-[methyl-(2-methylcarbamoyl-ethyl)-carbamoyl]-cyclohexyl}-ethyl)-carbamate
01/13/2005US20050009816 Potassium channel modulators
01/12/2005EP1495034A2 Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses
01/12/2005EP1259502B1 Biologically active analogs of discodermolide
01/12/2005EP1171423B1 Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands
01/11/2005US6841667 Nucleophilic kinetic resolution of cyclic substrates using silyl azides
01/06/2005WO2005000803A2 Asymmetric urea compound and process for producing asymmetric compound by asymmetric conjugate addition reaction with the same as catalyst
01/05/2005EP1492766A1 Improved cc-1065 analog synthesis
01/05/2005CN1561333A Aromatic and heteroaromatic acid halides for synthesizing polyamides
01/05/2005CN1561327A Novel aminobenzoephenones
01/05/2005CN1561326A Alpha-haloenamine reagents
01/04/2005US6838470 Antiischemic agents; brain disorders; cardiovascular disorders
01/02/2005WO2006125451A1 Hydroxyalkylamides
01/02/2005CA2530195A1 Hydroxyalkylamides
12/2004
12/29/2004WO2004113295A1 Process and intermediates for the preparation of (1r,2s,5s)-6,6-dimethyl-3-azabicyclo[3,1,0]hexane-2-carboxylates or salts thereof
12/29/2004WO2004113294A1 Process and intermediates for the preparation of (1r, 2s, 5s)-3-azabicyclo[3, 1, 0]hexane-2-carboxamide, n-[3-amino-1-(cyclobutylmethyl)-2, 3-dioxopropyl] ]-3-[(2s)-2-[[[1, 1-dimethylethyl]amino]carbonylamino]-3, 3-dimethyl-1-oxobutyl]-6, 6-dimethyl
12/29/2004WO2004113272A1 Process and intermediates for the preparation of 3-(amino)-3-cyclobutylmethyl-2-hydroxy-propionamide or salts thereof
12/29/2004WO2004113265A1 Flame retardant polymers
12/29/2004EP1491525A1 Process for producing beta-aminoketone and catalyst therefor
12/29/2004EP1490328A1 Compositions and methods for inhibition of phospholipase a2 mediated inflammation
12/29/2004EP1490324A2 Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective mao inhibitors
12/29/2004EP1490043A2 Spirocyclic amides as cannabinoid receptor modulators
12/29/2004EP1206442A4 Substituted chiral allosteric hemoglobin modifiers
12/29/2004CN1181825C Use of colchinol derivatives in preparation of vascular damaging agents drug
12/23/2004WO2004110989A1 N-hydroxy-7-(arylamino)heptanamide derivatives useful for treating hyper-proliferative disorders
12/23/2004WO2004110980A1 Sphingolipids' polyalkylamines conjugates
12/23/2004WO2004110499A1 Sphingolipids polyalkylamine conjugates for use in transfection
12/23/2004WO2004110496A1 Sphingoid polyalkylamine conjugates for vaccination
12/23/2004CA2528402A1 Sphingoid polyalkylamine conjugates for vaccination
12/22/2004EP1487788A1 Diaminoacid-aminoacid-polyamine based gemini surfactant compounds
12/22/2004EP1080066A4 Bioreductive cytotoxic agents
12/22/2004CN1181050C Noval substituted dimeric compounds, its preparing process and medicinal composition containing same
12/22/2004CN1181046C Prepn process of chiral compound L-homophenproobamate and its salt
1 ... 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 ... 157